01
Basic Science
Molecular markers, methylation classification, and the cellular and immune microenvironment driving meningioma biology.
28 September 2026 Rome, Italy
Basic Science · Translation · Clinics
About the symposium
A focused, single-track meeting bringing together international leaders in meningioma research and clinical care — bridging molecular biology, translational science, and clinical practice.
01
Molecular markers, methylation classification, and the cellular and immune microenvironment driving meningioma biology.
02
Preclinical models, host factors, and biomarker-guided strategies that move discoveries from the bench toward patients.
03
Surgical innovation, radiation, systemic options, and integrated treatment paradigms shaping contemporary meningioma management.
Programme · 28 September 2026
A single-track day designed for depth and discussion. Each session pairs invited talks with selected abstract presentations and an open roundtable.
Arie Perry San Francisco · Wenya Linda Bi Boston · Felix Sahm Heidelberg
+ selected abstract presentations
Jennifer Moliterno New Haven · Murat Günel New Haven
+ selected abstract presentations
Matthieu Peyre Paris · Christel Herold-Mende Heidelberg · David Raleigh San Francisco
Jonathan Kipnis St. Louis · Christian Mawrin Magdeburg
+ roundtable & concluding remarks
Faculty
Confirmed faculty from leading centres in Europe and North America. Further speakers to be announced.
San Francisco
Molecular Markers
Boston
Molecular Markers
Heidelberg
Molecular Markers
New Haven
Treatment
New Haven
Treatment
Paris
Models
Heidelberg
Models
San Francisco
Models
St. Louis
Host Factors
Magdeburg
Host FactorsSubmissions & updates
A quick snapshot of the most relevant submission and programme updates ahead of the meeting.
Registration is now open. Secure your place at the symposium here.
The late-breaking abstract submission deadline has passed. Authors will be notified in due course.
The regular call for abstracts has closed. Reviewers are evaluating submissions; authors will be notified in due course.
The symposium takes place on Isola Tiberina — the small island in the Tiber at the heart of Rome, a place dedicated to medicine and healing since antiquity.
Participants are encouraged to plan their travel early to make the most of the day in Rome and the surrounding academic community.
Registration is now open. Secure your place at the symposium.
Register nowEarly registration until 12 August 2026
| Category | Fee (EUR, incl. 22% VAT) |
|---|---|
| Regular | EUR 250 |
| EANO / SNO Member | EUR 125 |
| Nurse / AHP regular | EUR 80 |
| Nurse / AHP EANO / SNO Member | EUR 40 |
| PhD Student / Resident / Trainee regular | EUR 80 |
| PhD Student / Resident / Trainee EANO / SNO Member | EUR 40 |
| Industry representative | EUR 700 |
Late / Onsite registration after 12 August 2026
| Category | Fee (EUR, incl. 22% VAT) |
|---|---|
| Regular | EUR 550 |
| EANO / SNO Member | EUR 275 |
| Nurse / AHP regular | EUR 160 |
| Nurse / AHP EANO / SNO Member | EUR 80 |
| PhD Student / Resident / Trainee regular | EUR 160 |
| PhD Student / Resident / Trainee EANO / SNO Member | EUR 80 |
| Industry representative | EUR 900 |
Members of EANO (European Association of Neuro-Oncology) and SNO (Society for Neuro-Oncology) are eligible for the reduced member rate.
Cancellations must be submitted in writing to meningiomasymposium@wma.co.at. Consumers have the right to withdraw within 14 days of registration, provided access to the conference has not yet been requested.